Description

• PNC-28 (20mg) is a synthetic research peptide that has been evaluated in laboratory studies for its roles in cancer biology, apoptosis, and tumor-related pathways.

• Experimental investigations have explored its interaction with p53-associated mechanisms and its effects on programmed cell death in preclinical models.

• Research has examined PNC-28 (20mg) in the context of oncology, cell cycle regulation, mitochondrial function, and cancer pathway studies.

• This peptide is provided strictly for laboratory research use only and is not intended for human consumption, diagnostic, or therapeutic applications.